ACL.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 14, 2025
Report Source: 2025 Annual Report
Australian Clinical Labs Ltd. Stock Analysis ACL.AX
Australian Clinical Labs Ltd. engages in the provision of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. The company performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. The company has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.
Read More Australian Clinical Labs Ltd (ACL.AX) Chart
Key Statistics of Australian Clinical Labs Ltd (ACL.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD1.85Volume
760.77KP/E Ratio (TTM)
11.0552 Week Range
Market Cap
360.33MAvg. Volume
333.50KDividend Yield
6.81%Financial Metrics & Statements of Australian Clinical Labs Ltd (ACL.AX)
FAQ's for Australian Clinical Labs Ltd (ACL.AX)
- According to Musaffa’s Shariah screening methodology, Australian Clinical Labs Ltd (ACL.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.